<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Commun Signal</journal-id><journal-id journal-id-type="iso-abbrev">J Cell Commun Signal</journal-id><journal-title-group><journal-title>Journal of Cell Communication and Signaling</journal-title></journal-title-group><issn pub-type="ppub">1873-9601</issn><issn pub-type="epub">1873-961X</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7438026</article-id><article-id pub-id-type="publisher-id">579</article-id><article-id pub-id-type="doi">10.1007/s12079-020-00579-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bits and Bytes</subject></subj-group></article-categories><title-group><article-title>Repurposing calcium channel blockers as antiviral drugs</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7884-5466</contrib-id><name><surname>Jayaseelan</surname><given-names>Vijayashree Priyadharsini</given-names></name><address><email>vijayashreej.sdc@saveetha.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Paramasivam</surname><given-names>Arumugam</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.412431.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0444 045X</institution-id><institution>BRULAC-DRC, Saveetha Dental College &#x00026; Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], </institution><institution>Saveetha University, </institution></institution-wrap>Poonamallee High Road, Chennai, Tamil Nadu 600077 India </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>8</month><year>2020</year></pub-date><fpage>1</fpage><lpage>2</lpage><history><date date-type="received"><day>12</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The International CCN Society 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The current pandemic caused by the SARS-CoV-2 has claimed over a half a million lives within a very short span of time. A therapeutic drug which could prevent the entry and propagation of the virus is the need of the hour. Several lines of evidence collected from experimental studies older than three decades have pointed out the fact that inhibiting calcium entry into cells can affect vital steps in the lifecycle of viruses. Hence, calcium channel blockers may be considered as an effective measure in the containment of the viruses. This commentary throws light two scientific papers although with divergent facts converging at a point by suggesting a promising treatment option for CoVID-19 (Fang et al. Lancet Respir Med 8:e21, <xref ref-type="bibr" rid="CR4">2020</xref>; Straus et al. J Virol 94:e00426, <xref ref-type="bibr" rid="CR11">2020</xref>).</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>CCB </kwd><kwd>Calcium homeostasis</kwd><kwd>Calcium channels</kwd><kwd>SARs</kwd><kwd>Virus</kwd><kwd>Verapamil</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001843</institution-id><institution>Science and Engineering Research Board</institution></institution-wrap></funding-source><award-id>CRG/2019/003756</award-id><principal-award-recipient><name><surname>Jayaseelan</surname><given-names>Vijayashree Priyadharsini</given-names></name></principal-award-recipient></award-group></funding-group></article-meta></front><body><p id="Par2">The association of CoVID-19 infection with co-morbid conditions such as diabetes and hypertension is considered to be a fatal combination in elderly population. The process of host cell invasion is initiated by the recognition of ACE2 receptor (Angiotensin converting enzyme 2) expressed in the epithelial cells of major organs such as lung, kidney and intestine (Fang et al. <xref ref-type="bibr" rid="CR4">2020</xref>; Paramasivam et al. <xref ref-type="bibr" rid="CR10">2020</xref>). ACE inhibitors, angiotensin II type-I receptor blockers (ARBs), thiazolidinediones and ibuprofen have been reported to increase the expression of ACE2, thereby increasing the risk of infection (Kai and Kai <xref ref-type="bibr" rid="CR5">2020</xref>; Li et al. <xref ref-type="bibr" rid="CR6">2020</xref>). An alternative strategy could be to use other forms of anti-hypertensive drugs with a special emphasis on calcium channel blockers. Why calcium channel blockers? Viruses greatly rely on host&#x02019;s calcium homeostasis to modulate signal transduction pathways in its favour. As convincing reports on calcium channel blockers mediated increase in ACE2 expression has not been documented so far, these drugs can be a safe alternative for treating CoVID patients with hypertension.</p><p id="Par3">Host cells are found to modulate calcium signalling in response to viral infection and the viruses in-turn harness this environment for their own survival and propagation. Elevation in cytosolic calcium concentration and influx of calcium into mitochondria supports viral replication. Regulation of calcium in endoplasmic reticulum (ER) and Golgi apparatus, further aids in the inhibition of host protein trafficking and viral protein maturation. Various calcium channels promote the lifecycle of virus in the cell by supporting entry, replication, assembly and release of virions. Elevated calcium influx via store-operated calcium channels (SOC) contribute to the establishment of infection due to rotavirus. The transient receptor potential channel (TRP) is known to be associated with hypersensitivity induced by chemical or thermal stimuli. Infection of human bronchial epithelial cells by respiratory viruses including respiratory syncytial virus (RSV), measles virus (MV) and rhinovirus (RV) was found to increase the expression of TRP channels in human bronchial epithelial cells. The over-expression of TRP proteins provides a favourable environment for propagation of virus (Chen et al. <xref ref-type="bibr" rid="CR2">2019</xref>; Omar et al. <xref ref-type="bibr" rid="CR9">2017</xref>). Infections caused by influenza A virus was successfully contained by Verapamil, a drug to treat hypertension, atrial fibrillation and angina. Compounds blocking L-type calcium channels such as nimodipine, diltiazem etc., and a blocker of voltage gated calcium channel (VGCC) was found to inhibit Ebola virus in vivo. Hence targeting calcium channels might resolve issues pertaining to viral infections.</p><p id="Par4">A recent study demonstrated that over a two-fold increase in intracellular Ca<sup>2+</sup> enhanced the fusogenic ability of MERS-CoV. A similar study on SARS-CoV provided substantial evidence on the requirement of Ca<sup>2+</sup> by the bipartite fusion platform of the viral peptide enabling fusion and entry into the host cells. Furthermore, the entry of virions through plasma membrane and endosomes were significantly reduced upon depletion of intra and extracellular calcium ions (Straus et al. <xref ref-type="bibr" rid="CR11">2020</xref>). More recent studies on Ebola virus have also reinforced the fact that Ca<sup>2+</sup> ions enhanced their entry via interactions with negatively charged residues D522 and E540 of the fusion peptide (Nathan et al. <xref ref-type="bibr" rid="CR8">2020</xref>). Research by Chang and colleagues on the dysregulation of calcium homeostasis during Rota virus infection also validated the fact. A nonstructural glycoprotein (NSP4) localized on the ER acts as a viroporin or virus encoded ion channel to mediate efflux of Ca<sup>2+</sup> ions from the ER. A sustained increase in cytosolic Ca<sup>2+</sup> and decreased ER Ca<sup>2+</sup> is sensed by stromal interaction molecule 1 which in turn assists the entry of Ca<sup>2+</sup> through SOC (Chang-Graham et al. <xref ref-type="bibr" rid="CR1">2019</xref>).</p><p id="Par5">A very recent report had re-proposed the use of verapamil as modulators of endosomal trafficking, by inhibition of both Ca<sup>2+</sup> and K<sup>+</sup> channels in Simian virus 40 (SV40). In addition, they proved that Merkel cell polyomavirus (MCPyV) and SV40 inevitably rely on two-pore Ca<sup>2+</sup> channels (TPC)&#x000a0;for capsid disassembly and nuclear transport which was blocked using tetrandrine, a TPC specific blocker (Dobson et al. <xref ref-type="bibr" rid="CR3">2020</xref>). Interestingly, in an attempt made to identify genetic variants associated with susceptibility to neuro-invasive disease caused by West Nile virus, CASNA1H (Calcium Voltage-Gated Channel Subunit Alpha1 H) achieved a genome-wide significance implying the fact that ion-channels could be as important as other immuno-modulatory proteins controlling host response to viral infections (Long et al. <xref ref-type="bibr" rid="CR7">2016</xref>). Taken together, investigations on common pathways employed by different viruses to create an intracellular Ca<sup>2+</sup> storm potentiating the needs of the virus to propagate within the host cells would lead to identification of those prescription drugs as a magical cure for sudden pandemics. Extensive research on existing calcium channel blockers intended for use as anti-hypertensives might as well aid in repurposing these drugs into the anti-viral regimen.</p></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par6">None.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang-Graham</surname><given-names>AL</given-names></name><name><surname>Perry</surname><given-names>JL</given-names></name><name><surname>Strtak</surname><given-names>AC</given-names></name><name><surname>Ramachandran</surname><given-names>NK</given-names></name><name><surname>Criglar</surname><given-names>JM</given-names></name><name><surname>Philip</surname><given-names>AA</given-names></name><name><surname>Patton</surname><given-names>JT</given-names></name><name><surname>Estes</surname><given-names>MK</given-names></name><name><surname>Hyser</surname><given-names>JM</given-names></name></person-group><article-title>Rotavirus calcium dysregulation manifests as dynamic calcium signaling in the cytoplasm and endoplasmic reticulum</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>10822</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-46856-8</pub-id><pub-id pub-id-type="pmid">31346185</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name></person-group><article-title>Host calcium channels and pumps in viral infections</article-title><source>Cells</source><year>2019</year><volume>9</volume><issue>1</issue><fpage>94</fpage><pub-id pub-id-type="doi">10.3390/cells9010094</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>SJ</given-names></name><name><surname>Mankouri</surname><given-names>J</given-names></name><name><surname>Whitehouse</surname><given-names>A</given-names></name></person-group><article-title>Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking</article-title><source>Antivir Res</source><year>2020</year><volume>7</volume><fpage>104819</fpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104819</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Karakiulakis</surname><given-names>G</given-names></name><name><surname>Roth</surname><given-names>M</given-names></name></person-group><article-title>Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?</article-title><source>Lancet Respir Med</source><year>2020</year><volume>8</volume><fpage>e21</fpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30116-8</pub-id><pub-id pub-id-type="pmid">32171062</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Kai</surname><given-names>M</given-names></name></person-group><article-title>Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors&#x02014;lessons from available evidence and insights into COVID-19</article-title><source>Hypertens Res</source><year>2020</year><volume>43</volume><issue>7</issue><fpage>648</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1038/s41440-020-0455-8</pub-id><pub-id pub-id-type="pmid">32341442</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Antihypertensive treatment with ACEI/ARB of patients with COVID19 complicated by hypertension</article-title><source>Hypertens Res</source><year>2020</year><volume>43</volume><issue>6</issue><fpage>588</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/s41440-020-0433-1</pub-id><pub-id pub-id-type="pmid">32231220</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>D</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Loeb</surname><given-names>M</given-names></name><name><surname>Lauring</surname><given-names>AS</given-names></name><name><surname>Seielstad</surname><given-names>M</given-names></name></person-group><article-title>Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease</article-title><source>Genes Immun</source><year>2016</year><volume>7</volume><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/gene.2016.21</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>L</given-names></name><name><surname>Lai</surname><given-names>AL</given-names></name><name><surname>Millet</surname><given-names>JK</given-names></name><name><surname>Straus</surname><given-names>MR</given-names></name><name><surname>Freed</surname><given-names>JH</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name><name><surname>Daniel</surname><given-names>S</given-names></name></person-group><article-title>Calcium ions directly interact with the Ebola virus fusion peptide to promote structure-function changes that enhance infection</article-title><source>ACS Infect Dis</source><year>2020</year><volume>6</volume><fpage>250</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00296</pub-id><pub-id pub-id-type="pmid">31746195</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omar</surname><given-names>S</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Abdullah</surname><given-names>H</given-names></name><name><surname>Brady</surname><given-names>C</given-names></name><name><surname>Corry</surname><given-names>J</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name><name><surname>Touzelet</surname><given-names>O</given-names></name><name><surname>Power</surname><given-names>UF</given-names></name><name><surname>Lundy</surname><given-names>F</given-names></name><name><surname>McGarvey</surname><given-names>LPA</given-names></name><name><surname>Cosby</surname><given-names>SL</given-names></name></person-group><article-title>Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>12</issue><fpage>e0171681</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0171681</pub-id><pub-id pub-id-type="pmid">28187208</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paramasivam</surname><given-names>A</given-names></name><name><surname>Vijayashree Priyadharsini</surname><given-names>J</given-names></name><name><surname>Raghunandhakumar</surname><given-names>S</given-names></name><name><surname>Elumalai</surname><given-names>P</given-names></name></person-group><article-title>A novel COVID-19 and its effects on cardiovascular disease</article-title><source>Hypertens Res</source><year>2020</year><volume>43</volume><issue>7</issue><fpage>729</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/s41440-020-0461-x</pub-id><pub-id pub-id-type="pmid">32355222</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straus</surname><given-names>MR</given-names></name><name><surname>Tang</surname><given-names>T</given-names></name><name><surname>Al</surname><given-names>L</given-names></name><name><surname>Flegel</surname><given-names>A</given-names></name><name><surname>Bidon</surname><given-names>M</given-names></name><name><surname>Freed</surname><given-names>JH</given-names></name><name><surname>Daniel</surname><given-names>S</given-names></name><name><surname>Whittaker</surname><given-names>GR</given-names></name></person-group><article-title>Ca<sup>2+</sup> ions promote fusion of Middle East respiratory syndrome coronavirus with host cells and increase infectivity</article-title><source>J Virol</source><year>2020</year><volume>94</volume><fpage>e00426</fpage><lpage>e00420</lpage><pub-id pub-id-type="doi">10.1128/JVI.00426-20</pub-id><pub-id pub-id-type="pmid">32295925</pub-id></element-citation></ref></ref-list></back></article>